Cargando…

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

Due to the need for new chemical entities for cardiovascular diseases, we have synthesized a new series of nitrate−coumarins and evaluated their vasorelaxant activity in contraction‐relaxation studies using rat aorta rings precontracted with phenylephrine or by depolarization with a high concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Matos, Maria João, Uriarte, Eugenio, Seoane, Nuria, Picos, Aitor, Gil‐Longo, José, Campos‐Toimil, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827831/
https://www.ncbi.nlm.nih.gov/pubmed/36109344
http://dx.doi.org/10.1002/cmdc.202200476
Descripción
Sumario:Due to the need for new chemical entities for cardiovascular diseases, we have synthesized a new series of nitrate−coumarins and evaluated their vasorelaxant activity in contraction‐relaxation studies using rat aorta rings precontracted with phenylephrine or by depolarization with a high concentration of potassium chloride. Four of the new compounds were able to relax smooth vascular muscle with a similar profile and potency to glyceryl trinitrate (IC(50)=12.73 nM) and sodium nitroprusside (IC(50)=4.32 nM). Coumarin‐7‐yl‐methyl nitrate (4), the best compound within the series, was able to relax smooth vascular muscle in the low nanomolar range (IC(50)=1.92 nM). The mechanisms of action have been explored, being the activation of sGC and the opening of K(+) channels involved. Our studies indicate that the new nitrate derivatives are reversible and not deleterious for aortic rings, suggesting that these compounds have a potential interest for the development of new and highly efficient vasodilator drugs.